-
Global Pulmonary Arterial Hypertension (PAH) Drugs Market Report 2022 to 2027: Key Players Include Arena Pharmaceuticals, AstraZeneca, Bayer Aktiengesellschaft and Daiichi Sankyo - ResearchAndMarkets.com
03 Feb 2023 10:55 GMT
… Pharmaceuticals Ltd (Johnson & Johnson)
Arena Pharmaceuticals Inc.
AstraZeneca PLC
Bayer Aktiengesellschaft … administered.
The increasing prevalence of cardiovascular and pulmonary disorders is one …
-
Esperion Appoints Robert E. Hoffman to Board of Directors
01 Apr 2025 12:00 GMT
… and Chief Financial Officer of Arena Pharmaceuticals, Inc. (“Arena”) until its sale … who are at risk for cardiovascular disease and are struggling with … nearly 14,000 patient CLEAR Cardiovascular Outcomes Trial. Esperion continues to …
-
Pfizer Completes Acquisition of Arena Pharmaceuticals
12 Mar 2022 06:52 GMT
… completion of its acquisition of Arena Pharmaceuticals, a clinical stage company … several immuno-inflammatory diseases.
Arena Pharmaceuticals brings to Pfizer a portfolio … also includes two development-stage cardiovascular assets: temanogrel for microvascular …
-
Pfizer Completes Acquisition of Arena Pharmaceuticals
11 Mar 2022 13:34 GMT
… completion of its acquisition of Arena Pharmaceuticals, a clinical stage company … several immuno-inflammatory diseases.
Arena Pharmaceuticals brings to Pfizer a portfolio … also includes two development-stage cardiovascular assets: temanogrel for microvascular …
-
Pfizer to buy Arena Pharmaceuticals in $6.7 billion deal
16 Dec 2021 08:00 GMT
… inked a deal to buy Arena Pharmaceuticals in an all-cash deal … pipeline includes two earlier-stage cardiovascular treatments. The first, temanogrel, is …
-
Opportunity and New Therapies Are Driving Interest in a Rare Cardiovascular D...
07 Aug 2023 06:01 GMT
… Therapeutics, which in 2018 paid Arena Pharmaceuticals a potential $1.2 billion … Patel, a healthcare analyst in cardiovascular and metabolic disorders at GlobalData … global clinical development at Merck Cardiovascular, this anti-proliferation approach means …
-
Pfizer to Acquire Arena Pharmaceuticals
13 Dec 2021 11:45 GMT
Pfizer Inc. (NYSE: PFE) and Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced … pipeline includes two development-stage cardiovascular assets, temanogrel and APD418. Temanogrel … at least 90 days.
About Arena Pharmaceuticals
ARENA is a team with …
-
Sphingosine 1 Phosphate Receptor (S1pr) Modulator Drugs Market Analysis: Key Trends, Share, Growth Drivers
28 Mar 2025 14:23 GMT
… Company, Juvisé Pharmaceuticals, Priothera Limited, Arena Pharmaceuticals.
What are the emerging trends …
3 By Application: Multiple Sclerosis, Cardiovascular Diseases, Transplant Rejection
4 By …
-
Arena Pharmaceuticals, inc (ARNA) Q2 2021 Earnings Call Transcript
06 Aug 2021 13:00 GMT
Image source: The Motley Fool.
Arena Pharmaceuticals, inc (NASDAQ:ARNA)
Q2 2021 … gentlemen, and welcome to the Arena Pharmaceuticals Second Quarter 2021 Update. At … and temanogrel in their respective cardiovascular indications.
Now I'll …
-
Belviq Colorectal Cancer Lawsuit Filed Against Eisai, Arena Pharmaceuticals
17 Jun 2021 18:18 GMT
Eisai, Inc. and Arena Pharmaceuticals concealed information about the link … largest concern at the time: cardiovascular risks.
While not publicly announced …
About
© 1995-2025